Aoxing Pharmaceutical Company, Inc.

Total Valuation

Aoxing Pharmaceutical Company, Inc. carries a market capitalization of 320,107.00, placing it among publicly traded companies globally. Its enterprise value stands at 50.29M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Aoxing Pharmaceutical Company, Inc. currently has 76.21M shares outstanding.

Valuation Ratios

Aoxing Pharmaceutical Company, Inc. trades at a trailing price-to-earnings ratio of 44.78. The price-to-sales ratio is 1.02, and the price-to-book ratio stands at -0.55.

Enterprise Valuation

On an enterprise value basis, Aoxing Pharmaceutical Company, Inc. trades at an EV/EBITDA multiple of 25.74 and an EV/FCF ratio of 220.47. The EV/Sales ratio of 1.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 51.99 provides insight into valuation relative to core operating earnings.

Financial Position

Aoxing Pharmaceutical Company, Inc. maintains a current ratio of 0.79, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 153.29, indicating elevated leverage, while an interest coverage ratio of 3.05 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Aoxing Pharmaceutical Company, Inc. has paid -408,979.00 in income taxes, reflecting an effective tax rate of 114.18.

Stock Price Statistics

Aoxing Pharmaceutical Company, Inc.'s stock has declined approximately -47.5% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.

Income Statement

Over the trailing twelve months, Aoxing Pharmaceutical Company, Inc. generated 30.11M in revenue and converted that into -1.46M in net income, yielding earnings per share of -0.02. EBITDA reached 1.95M, while operating income came in at 967,218.00.

Balance Sheet

Aoxing Pharmaceutical Company, Inc. holds 7.08M in cash and equivalents against 27.72M in total debt, resulting in a net debt position of 20.64M. Total book value stands at -55.78M, with working capital of -9.17M providing operational flexibility.

Cash Flow

Aoxing Pharmaceutical Company, Inc. produced -1.36M in operating cash flow over the past twelve months. After subtracting -30,267.00 in capital expenditures, free cash flow totaled -1.39M - equivalent to -0.02 per share.

Margins

Aoxing Pharmaceutical Company, Inc. operates with a gross margin of 76.19, reflecting its pricing power and cost economics. The operating margin of 3.21 and net profit margin of -4.86 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Aoxing Pharmaceutical Company, Inc.'s most recent stock split took place on March 29, 2010 with a 2:1 split ratio.

Scores

Aoxing Pharmaceutical Company, Inc. posts an Altman Z-Score of -0.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.